Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Northwest Biotherapeutics (NWBO) over the last 6 years, with Dec 2024 value amounting to $1.2 million.

  • Northwest Biotherapeutics' Shares Outstanding (Diluted Average) rose 18.56% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 18.56%. This contributed to the annual value of $1.2 million for FY2024, which is 10.99% up from last year.
  • Per Northwest Biotherapeutics' latest filing, its Shares Outstanding (Diluted Average) stood at $1.2 million for FY2024, which was up 10.99% from $1.1 million recorded in FY2023.
  • In the past 5 years, Northwest Biotherapeutics' Shares Outstanding (Diluted Average) ranged from a high of $1.2 million in FY2024 and a low of $725,129 during FY2020.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $1.1 million, with a median of $1.1 million in 2023.
  • Data for Northwest Biotherapeutics' Shares Outstanding (Diluted Average) shows a peak YoY spiked of 38.99% (in 2021) over the last 5 years.
  • Over the past 5 years, Northwest Biotherapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $725,129 in 2020, then soared by 38.99% to $1.0 million in 2021, then increased by 0.79% to $1.0 million in 2022, then climbed by 10.17% to $1.1 million in 2023, then climbed by 10.99% to $1.2 million in 2024.